MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients
In order to study the putative monoamine oxidase (MAO) inhibitory side effect of neuroleptics and simultaneous changes in platelet serotonin content both MAO-B activity and serotonin (5-HT) content in platelets of 30 healthy volunteers and 50 schizophrenic patients treated with neuroleptics were investigated. Our results have shown significantly lower MAO-B activity (15.26 ± 6.81 S.D. vs. 8.63 ± 3.82mmol/hour/109 platelets) and higher platelet 5-HT content (906.19 ± 285.33 vs. 1,727.85 ± 947.40ng/109 platelets) in the schizophrenic group. Platelet MAO-B activity was considerably lower in paranoid and residual schizophrenics compared with other patients, however, no difference was found in platelet 5-HT content between different subtypes of schizophrenia. Various neuroleptic treatments did not produce different effects either on platelet serotonin content or platelet MAO-B activity.
KeywordsPlatelet Rich Plasma Neuroleptic Treatment Serotonin Content Platelet Serotonin Monoamine Oxidase Activity
Unable to display preview. Download preview PDF.
- Celada P, Sarrias MJ, Artigas F (1990) Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. J Neural Transm [Suppl] 32: 149–154Google Scholar
- Watanabe K, Kobayashi S, Oguchi K (1990) Microdetermination of human platelet MAO activity. Showa Med Lett 44(2): 205–211Google Scholar